Clinical Trials Directory

Trials / Completed

CompletedNCT05001048

Sex Differences in Sympathetic Activity and Vascular Reactivity During Acute and Chronic Hypoxia.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate sex differences in blood pressure control associated with exposure to acute hypoxia (low oxygen), and short term acclimatization to hypoxia at high altitude.

Detailed description

About 200 million people worldwide live at high altitudes. Millions of others travel to high altitude every year for work or travel. The low oxygen (or hypoxia) experienced at high altitudes causes considerable physiological stress, and the body adapts in order to maintain adequate oxygen delivery to its tissues. One of these adaptations is an increase in the activity of the sympathetic nervous system. This system is responsible for the "fight or flight" response. Sympathetic activity regulates the size of the blood vessels, which will affect blood pressure. Previous studies suggest that males and females regulate their blood pressure in different ways. Females tend to have lower resting sympathetic activity, and less vasoconstriction in response to stressors than males. Blood pressure changes are also influenced by levels of sex hormones; for example, estrogen may cause opposing vasodilation. Therefore, it is important to understand the differences in how males and females respond to low oxygen. The main purpose of this study is to examine the differences between males and females in control of blood vessels during exposure to low oxygen. To study this question, we will test vasoreactivity to set physiological stressors in both males and females. Participants will be recruited at the Canadian sites, and we will test them while they breathe low oxygen for a short amount of time at low altitude. We will also perform assessments on the same participants during a two week stay at high altitude at White Mountain, CA, which is at an altitude of 3,800m. These data will have implications in the basic understanding of differences between male and female physiology. Specifically, to males and females living or travelling to high altitude.

Conditions

Interventions

TypeNameDescription
DRUGPhenylephrine HydrochlorideSeries of three incremental bolus injections to observe α1-adrenoreceptor mediated vasoconstriction.
OTHERCold Pressor TestStandardized sympathetic stressor involving submersion of the hand in ice-cold water for 3-minutes, aiming to elicit endogenous neurotransmitter release and blood pressure increases.
OTHERIsocapnic Acute HypoxiaDuring low altitude assessment, participants will be exposed to isocapnic hypoxia equivalent to 3,800m to assess responses to acute exposure.
OTHERHyperoxiaDuring high altitude assessments, participants will breathe an oxygen concentration comparable to their end-tidal values at low altitude for the assessment of the influences of acclimatization.

Timeline

Start date
2019-08-04
Primary completion
2021-12-07
Completion
2022-09-09
First posted
2021-08-11
Last updated
2022-10-31

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05001048. Inclusion in this directory is not an endorsement.